Patent · US Active

Antibodies to risperidone and use thereof

US10852313B2 · kind B2 · utility

0Cited by

35References

20Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Eric Hryhorenko · Hilton, US
Banumathi Sankaran · Lexington, US
Thomas R. DeCory · Pittsford, US
Theresa Tubbs · Rochester, US
Linda Colt · Rochester, US
Maarten Vliegen · Rijkevorsel, BE
Pieter Rik Haspeslagh · Halen, BE

Key dates

Filing date	Sep 30, 2019
Grant date	Dec 1, 2020
Priority date	—
Expiry date	Sep 30, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/565
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an antibody or a binding fragment thereof that binds to risperidone, which can be used to detect risperidone in a sample such as in a competitive immunoassay method. The antibody or fragment thereof can be used in a lateral flow assay device for point-of-care detection of risperidone, including multiplex detection of aripiprazole, quetiapine, olanzapine, and risperidone in a single lateral flow assay device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.